These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 22942288

  • 21. N4-monobutyryl-cCMP activates PKA RIα and PKA RIIα more potently and with higher efficacy than PKG Iα in vitro but not in vivo.
    Wolter S, Dove S, Golombek M, Schwede F, Seifert R.
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1163-75. PubMed ID: 25192685
    [Abstract] [Full Text] [Related]

  • 22. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P, Shah PK, Jo H, Lincoln TM.
    J Biol Chem; 1999 Nov 26; 274(48):34301-9. PubMed ID: 10567406
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
    Rudyk O, Eaton P.
    Free Radic Biol Med; 2017 Sep 26; 110():390-398. PubMed ID: 28690194
    [Abstract] [Full Text] [Related]

  • 25. Protein kinase G type-Ialpha phosphorylates the apoptosis-regulating protein Bad at serine 155 and protects against apoptosis in N1E-115 cells.
    Johlfs MG, Fiscus RR.
    Neurochem Int; 2010 Mar 26; 56(4):546-53. PubMed ID: 20043968
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E, Hervias I, Goñi-Allo B, Lasheras B, Jordan J, Aguirre N.
    J Neurochem; 2009 Feb 26; 108(3):755-66. PubMed ID: 19187094
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes.
    Fiedler B, Feil R, Hofmann F, Willenbockel C, Drexler H, Smolenski A, Lohmann SM, Wollert KC.
    J Biol Chem; 2006 Oct 27; 281(43):32831-40. PubMed ID: 16943189
    [Abstract] [Full Text] [Related]

  • 30. Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner.
    Ragu Varman D, Jayanthi LD, Ramamoorthy S.
    J Neurochem; 2021 Feb 27; 156(4):445-464. PubMed ID: 32797733
    [Abstract] [Full Text] [Related]

  • 31. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death.
    Rabkin SW, Tsang MY.
    Exp Physiol; 2008 Jul 27; 93(7):834-42. PubMed ID: 18344257
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy.
    Lau T, Horschitz S, Bartsch D, Schloss P.
    Neurochem Int; 2009 Jul 27; 54(3-4):271-6. PubMed ID: 19121357
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues.
    Ozaslan D, Wang S, Ahmed BA, Kocabas AM, McCastlain JC, Bene A, Kilic F.
    J Biol Chem; 2003 Nov 07; 278(45):43991-4000. PubMed ID: 12944413
    [Abstract] [Full Text] [Related]

  • 36. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
    Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H.
    Hypertension; 2002 Jan 07; 39(1):87-92. PubMed ID: 11799084
    [Abstract] [Full Text] [Related]

  • 37. Control of serotonin transporter phosphorylation by conformational state.
    Zhang YW, Turk BE, Rudnick G.
    Proc Natl Acad Sci U S A; 2016 May 17; 113(20):E2776-83. PubMed ID: 27140629
    [Abstract] [Full Text] [Related]

  • 38. Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6.
    Takahashi S, Lin H, Geshi N, Mori Y, Kawarabayashi Y, Takami N, Mori MX, Honda A, Inoue R.
    J Physiol; 2008 Sep 01; 586(17):4209-23. PubMed ID: 18617565
    [Abstract] [Full Text] [Related]

  • 39. Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
    Qin L, Sankaran B, Aminzai S, Casteel DE, Kim C.
    J Biol Chem; 2018 Jul 13; 293(28):10985-10992. PubMed ID: 29769318
    [Abstract] [Full Text] [Related]

  • 40. Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS/calmodulin/CaMKII signaling cascade.
    Chai Y, Zhang DM, Lin YF.
    PLoS One; 2011 Mar 29; 6(3):e18191. PubMed ID: 21479273
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.